Skip to main content

Table 1 Sex, tumor stage, and age of the samples from the ICGC database

From: N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma

 

Number

Ratio

Gender

Female

68

0.261538462

Male

192

0.738461538

Stage

Stage1

40

0.153846154

Stage2

117

0.45

Stage3

80

0.307692308

Stage4

23

0.088461538

Age

> 60

205

0.788461538

< 60

55

0.211538462

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us